🔥 Parataxis Acquires Korean Biotech Firm to Create Bitcoin Treasury
Parataxis Holdings will launch a Bitcoin treasury platform in South Korea through the acquisition of Bridge Biotherapeutics for 25 billion Korean won ($18.5 million). The company will be renamed Parataxis Korea and will operate as an institutional Bitcoin treasury, helping Korean institutions access BTC despite regulatory barriers.
South Korea currently does not allow ETFs and institutional crypto investments, but is testing the opening of “real-name” accounts for 3,500 corporations and professional investors by 2025.
Parataxis said it was inspired by models such as Strategy (US) and Metaplanet (Japan), expecting South Korea to be an important market in the institutional Bitcoin wave.
